title: Derangements of post-ischemic cerebral blood flow by protein kinase C delta.
abstract: Cerebral ischemia causes blood flow derangements characterized by hyperemia (increased cerebral blood flow, CBF) and subsequent hypoperfusion (decreased CBF). We previously demonstrated that protein kinase C delta (δPKC) plays an important role in hippocampal neuronal death after ischemia. However, whether part of this protection is due to the role of δPKC on CBF following cerebral ischemia remains poorly understood. We hypothesized that δPKC exacerbates hyperemia and subsequent hypoperfusion resulting in CBF derangements following ischemia. Sprague-Dawley (SD) rats pretreated with a δPKC specific inhibitor (δV1-1, 0.5 mg/kg) exhibited attenuation of hyperemia and latent hypoperfusion characterized by vasoconstriction followed by vasodilation of microvessels after 2-vessel occlusion plus hypotension measured by 2-photon microscopy. In an asphyxial cardiac arrest model (ACA), SD rats treated with δV1-1 (pre- and post-ischemia) exhibited improved perfusion after 24 h and less hippocampal CA1 neuronal death 7 days after ACA. These results suggest possible therapeutic potential of δPKC in modulating CBF and neuronal damage after cerebral ischemia.
authors.affiliation: Cerebral Vascular Disease Research Center, Department of Neurology, University of Miami, Miller School of Medicine, Miami, FL 33136, USA.
authors.forename: H W
authors.initials: HW
authors.lastname: Lin
authors.forename: R A
authors.initials: RA
authors.lastname: Defazio
authors.forename: D
authors.initials: D
authors.lastname: Della-Morte
authors.forename: J W
authors.initials: JW
authors.lastname: Thompson
authors.forename: S V
authors.initials: SV
authors.lastname: Narayanan
authors.forename: A P
authors.initials: AP
authors.lastname: Raval
authors.forename: I
authors.initials: I
authors.lastname: Saul
authors.forename: K R
authors.initials: KR
authors.lastname: Dave
authors.forename: M A
authors.initials: MA
authors.lastname: Perez-Pinzon
mesh_terms: D000818:Animals; D001237:Asphyxia / Q000150:complications; D001921:Brain / Q000098:blood supply / Q000378:metabolism / Q000473:pathology; D002545:Brain Ischemia / Q000473:pathology / Q000503:physiopathology*; D002470:Cell Survival / Q000187:drug effects; D002560:Cerebrovascular Circulation; D006323:Heart Arrest / Q000209:etiology / Q000503:physiopathology; D006940:Hyperemia / Q000517:prevention & control; D008297:Male; D008833:Microcirculation; D009474:Neurons / Q000187:drug effects / Q000473:pathology; D051745:Protein Kinase C-delta / Q000037:antagonists & inhibitors / Q000502:physiology*; D021381:Protein Transport; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D051745:Protein Kinase C-delta
references.citation: Brain Res. 2007 May 4;1144:146-55
references.pmid: 17350602
references.citation: Circulation. 2008 Feb 19;117(7):886-96
references.pmid: 18250271
references.citation: J Neurosci Res. 2005 Dec 1;82(5):665-73
references.pmid: 16247804
references.citation: Nature. 2004 Mar 11;428(6979):138-9
references.pmid: 15014486
references.citation: J Biol Chem. 1997 Jun 20;272(25):16010-7
references.pmid: 9188504
references.citation: Circ Res. 2002 Jul 12;91(1):62-9
references.pmid: 12114323
references.citation: Yonsei Med J. 1993 Mar;34(1):1-10
references.pmid: 8379180
references.citation: Apoptosis. 2003 Jan;8(1):19-27
references.pmid: 12510148
references.citation: Am J Physiol Heart Circ Physiol. 2004 Dec;287(6):H2461-7
references.pmid: 15319207
references.citation: Proc Natl Acad Sci U S A. 2007 Jan 2;104(1):365-70
references.pmid: 17190804
references.citation: J Neurosci. 2008 Apr 16;28(16):4172-82
references.pmid: 18417696
references.citation: Neurobiol Dis. 2005 Feb;18(1):126-33
references.pmid: 15649703
references.citation: Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11114-9
references.pmid: 11553773
references.citation: J Pharmacol Sci. 2008 Dec;108(4):446-54
references.pmid: 19057126
references.citation: Shock. 1997 Aug;8(2):95-101; discussion 102-3
references.pmid: 9261898
references.citation: J Cereb Blood Flow Metab. 1993 Mar;13(2):208-13
references.pmid: 8436612
references.citation: Ann N Y Acad Sci. 1989;559:269-81
references.pmid: 2549830
references.citation: J Stroke Cerebrovasc Dis. 2007 May-Jun;16(3):103-8
references.pmid: 17689403
references.citation: Exp Brain Res. 2007 Apr;178(4):470-6
references.pmid: 17091294
references.citation: J Vis Exp. 2009 May 14;(27):
references.pmid: 19444156
references.citation: Toxicol Sci. 2004 May;79(1):10-7
references.pmid: 14976340
references.citation: Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15741-6
references.pmid: 9861040
references.citation: Cerebrovasc Dis. 2006;21(3):145-53
references.pmid: 16401883
references.citation: J Cereb Blood Flow Metab. 2006 Sep;26(9):1114-21
references.pmid: 16736038
references.citation: J Cereb Blood Flow Metab. 1997 Feb;17(2):175-82
references.pmid: 9040497
references.citation: J Cereb Blood Flow Metab. 1993 Jul;13(4):541-9
references.pmid: 8314910
references.citation: Neurosci Lett. 2006 Aug 14;404(1-2):170-5
references.pmid: 16781056
references.citation: Arch Neurol. 1991 Jun;48(6):625-9
references.pmid: 2039385
references.citation: Resuscitation. 1993 Dec;26(3):225-35
references.pmid: 8134701
references.citation: J Clin Invest. 2004 Jul;114(1):49-56
references.pmid: 15232611
references.citation: Stroke. 1993 Oct;24(10):1590-7; discussion 1598
references.pmid: 8378966
references.citation: Nature. 1988 Mar 31;332(6163):411-5
references.pmid: 2451132
references.citation: Nat Neurosci. 2007 May;10(5):549-51
references.pmid: 17417634
references.citation: J Cereb Blood Flow Metab. 2005 Jun;25(6):730-41
references.pmid: 15716854
references.citation: Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13003-8
references.pmid: 11087855
references.citation: J Biol Chem. 1994 Apr 8;269(14):10444-50
references.pmid: 8144628
references.citation: Biochem Biophys Res Commun. 2004 Jun 11;318(4):949-54
references.pmid: 15147964
references.citation: Biochem Soc Trans. 2007 Nov;35(Pt 5):1040-2
references.pmid: 17956273
references.citation: Circulation. 2006 Jul 4;114(1 Suppl):I319-26
references.pmid: 16820593
references.citation: J Neurosci. 2004 Aug 4;24(31):6880-8
references.pmid: 15295022
references.citation: Nat Biotechnol. 1998 Oct;16(10):919-24
references.pmid: 9788346
references.citation: Neurochem Res. 1999 Dec;24(12):1499-505
references.pmid: 10591398
references.citation: Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12798-803
references.pmid: 10536002
references.citation: Int J Cardiol. 2009 Apr 3;133(2):256-9
references.pmid: 18242734
references.citation: Eur J Pharmacol. 1998 Apr 24;347(2-3):223-9
references.pmid: 9653886
references.citation: J Neurosci. 1995 Nov;15(11):7158-67
references.pmid: 7472470
references.citation: J Biol Chem. 1997 Dec 5;272(49):30945-51
references.pmid: 9388241